ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

44 hedge funds and large institutions have $164M invested in Alpine Immune Sciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 6 closing their positions.

Holders
44
Holders Change
-3
Holders Change %
-6.38%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
4
Increased
18
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
1
BVF Inc
California
$17M
2
O
2
OrbiMed
New York
$43.6M
3
OFM
3
Omega Fund Management
Massachusetts
$21.7M
4
APM
4
Avidity Partners Management
Texas
$20.6M
5
LGM
5
Logos Global Management
California
$4.54M

Top Sellers

1
FM
1
Frazier Management
Washington
$18.9M
2
EC
2
EcoR1 Capital
California
$75K
3
IC
3
Ikarian Capital
Texas
$0
4
SB
4
Samsara BioCapital
California
$0
5
Deutsche Bank
5
Deutsche Bank
Germany
$71K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
51
Concourse Financial Group Securities
Alabama
– – – –
1 2
3